A Study of E6005 in Japanese Patients With Atopic Dermatitis

Phase 1

Completed

• Conditions: Atopic Dermatitis
• Interventions: Drug: Placebo; Drug: E6005

• Registration Number: NCT01179880
• Lead Sponsor: Dermavant Sciences GmbH

Brief Summary

The safety and pharmacokinetics of topical application with E6005 ointment compared to vehicle will be evaluated in Japanese male patients with atopic dermatitis. Additionally, the efficacy of topical application with E6005 ointment will be explored in Japanese male patients with atopic dermatitis.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2010-08-04
• Study First Submitted QC: 2010-08-09
• Study First Posted: 2010-08-11
• Study Start: 2010-09
• Primary Completion: 2012-12
• Study Completion: 2012-12
• Status Verified: 2018-02
• Last Update Submitted: 2018-02-28
• Last Update Posted: 2018-03-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
2	Placebo	-
1	E6005	-

Primary Outcome Measures

Name	Time	Method
Pharmacokinetic parameter AUC(0-t) will be calculated	Until Day 13
Pharmacokinetic parameter Cmax will be calculated	Until Day 13
Pharmacokinetic parameter tmax will be calculated	Until Day 13
Pharmacokinetic parameter t1/2 will be calculated	Until Day 13